Form 4 for AGL agilon health, inc.
Accepted 2024-07-03 00:00:00 ET · period of report 2024-07-01 · accession 0001628280-24-031204 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-03 | 2024-07-01 | AGL | Schwaneke Jeffrey A. | CFO | A - Grant | $0.00 | +659.9K | 573.1K | New | $0 |
| D | 2024-07-03 | 2024-07-01 | AGL | Schwaneke Jeffrey A. | CFO | A - Grant | $0.00 | +239.1K | 239.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | A | A | 150,830 | $0.00 | 723,930 | D | — | — | (F4) Performance Stock Units may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date. (F2) Includes restricted stock units. |
| 2 | Common | Common Stock | 2024-07-01 | A | A | 377,074 | $0.00 | 441,124 | D | — | — | (F1) Restricted stock units that vest in three equal installments on each anniversary of July 1, 2024. (F2) Includes restricted stock units. |
| 3 | Common | Common Stock | 2024-07-01 | A | A | 131,976 | $0.00 | 573,100 | D | — | — | (F3) Restricted stock units that vest in four equal installments on each anniversary of July 1, 2024. (F2) Includes restricted stock units. |
| 4 | Derivative | Options (Rights to Buy) | 2024-07-01 | A | A | 239,072 | $0.00 | 239,072 | D | $6.07 · — to 2034-07-01 | 239,072 Common Stock | (F5) Options that vest in four equal installments on each anniversary of July 1, 2024. |